| Zacks Company Profile for MiMedx Group, Inc (MDXG : NSDQ) |
|
|
| |
| • Company Description |
| MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant.
Number of Employees: 837 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $6.78 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 716,748 shares |
| Shares Outstanding: 147.70 (millions) |
| Market Capitalization: $1,001.42 (millions) |
| Beta: 1.76 |
| 52 Week High: $10.14 |
| 52 Week Low: $5.47 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
10.78% |
6.64% |
| 12 Week |
1.50% |
-14.63% |
| Year To Date |
-29.52% |
-34.00% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Joseph H. Capper - Chief Executive Officer and Director
M. Kathleen Behrens - Chair of the Board
Doug Rice - Chief Financial Officer
James L. Bierman - Director
Cato T. Laurencin - Director
|
|
Peer Information
MiMedx Group, Inc (CORR.)
MiMedx Group, Inc (RSPI)
MiMedx Group, Inc (CGXP)
MiMedx Group, Inc (BGEN)
MiMedx Group, Inc (GTBP)
MiMedx Group, Inc (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 602496101
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
|
|
Share - Related Items
Shares Outstanding: 147.70
Most Recent Split Date: (:1)
Beta: 1.76
Market Capitalization: $1,001.42 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.07 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $0.26 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/30/25 |
|
|
|
| |
